Stay updated on Otelixizumab in New-Onset Type 1 Diabetes Clinical Trial
Sign up to get notified when there's something new on the Otelixizumab in New-Onset Type 1 Diabetes Clinical Trial page.

Latest updates to the Otelixizumab in New-Onset Type 1 Diabetes Clinical Trial page
- Check4 days agoChange DetectedThere are no additions or deletions documented for this page; the content remains as previously listed.SummaryDifference0.0%

- Check11 days agoChange DetectedRevision updated from v3.5.3 to v3.5.4 on the study detail page, signaling a minor platform/template update. The content and data shown for the study remain unchanged.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check33 days agoChange DetectedThe page revision/version indicator was updated from **v3.5.2** to **v3.5.3**, reflecting a site change rather than any modification to the study information shown.SummaryDifference0.0%

- Check40 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check69 days agoChange DetectedRevision: v3.5.0 has been added and Revision: v3.4.3 has been removed. This update is a metadata version change and does not affect the study content.SummaryDifference0.0%

- Check76 days agoChange DetectedRevision tag updated from v3.4.2 to v3.4.3; study content and details appear unchanged.SummaryDifference0.0%

Stay in the know with updates to Otelixizumab in New-Onset Type 1 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Otelixizumab in New-Onset Type 1 Diabetes Clinical Trial page.